1. Home
  2. XNCR vs ASA Comparison

XNCR vs ASA Comparison

Compare XNCR & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • ASA
  • Stock Information
  • Founded
  • XNCR 1997
  • ASA 1958
  • Country
  • XNCR United States
  • ASA United States
  • Employees
  • XNCR N/A
  • ASA N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • ASA Precious Metals
  • Sector
  • XNCR Health Care
  • ASA Industrials
  • Exchange
  • XNCR Nasdaq
  • ASA Nasdaq
  • Market Cap
  • XNCR 1.1B
  • ASA 945.7M
  • IPO Year
  • XNCR 2013
  • ASA N/A
  • Fundamental
  • Price
  • XNCR $13.86
  • ASA $46.11
  • Analyst Decision
  • XNCR Buy
  • ASA
  • Analyst Count
  • XNCR 11
  • ASA 0
  • Target Price
  • XNCR $24.20
  • ASA N/A
  • AVG Volume (30 Days)
  • XNCR 1.5M
  • ASA 170.5K
  • Earning Date
  • XNCR 11-06-2025
  • ASA 11-14-2025
  • Dividend Yield
  • XNCR N/A
  • ASA 0.13%
  • EPS Growth
  • XNCR N/A
  • ASA 335.96
  • EPS
  • XNCR N/A
  • ASA 19.90
  • Revenue
  • XNCR $146,929,000.00
  • ASA $3,982,215.00
  • Revenue This Year
  • XNCR $22.09
  • ASA N/A
  • Revenue Next Year
  • XNCR N/A
  • ASA N/A
  • P/E Ratio
  • XNCR N/A
  • ASA $2.31
  • Revenue Growth
  • XNCR N/A
  • ASA 99.75
  • 52 Week Low
  • XNCR $6.92
  • ASA $19.37
  • 52 Week High
  • XNCR $27.24
  • ASA $53.76
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 55.63
  • ASA 51.58
  • Support Level
  • XNCR $12.17
  • ASA $44.96
  • Resistance Level
  • XNCR $15.50
  • ASA $47.08
  • Average True Range (ATR)
  • XNCR 1.15
  • ASA 1.87
  • MACD
  • XNCR -0.12
  • ASA -0.54
  • Stochastic Oscillator
  • XNCR 49.86
  • ASA 28.12

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About ASA ASA Gold and Precious Metals Limited

ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.

Share on Social Networks: